-
Loading metrics
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS
- Takanori Ikeda,
- Satoshi Ogawa,
- Takanari Kitazono,
- Jyoji Nakagawara,
- Kazuo Minematsu,
- Susumu Miyamoto,
- Yuji Murakawa,
- Sanghun Iwashiro,
- Yutaka Okayama,
- Toshiyuki Sunaya
x
- Published: June 11, 2021
- https://doi.org/10.1371/journal.pone.0251325